Gempharmatech Flat at CNY 28.2: 22.6% Decline, Peers Stuck, Market Pause
Gempharmatech flat at CNY 28.2 after a 22.6% dip—2024 investors see a consolidation pause amid volatile peers, regulatory shifts, and liquidity dynamics.
3 minutes to read
GEMPHARMATECH CO LTD
Gempharmatech Stalls While China’s Drug Innovation Soars – Investor Alert
Gempharmatech stalls amid China’s drug‑innovation boom, lacking earnings data and momentum; investors face risk‑aided speculation vs. true value.
3 minutes to read